TABLE 1.
Demographic and clinical data of HSP patients and healthy control group.
HSP patients | Healthy controls | |
N = 31 | N = 36 | |
Gender | 16 F, 15 M | 26 F, 10 M |
Disease onset (years) | 27 ± 17 | |
Age at first MRI (years) | 43.5 ± 12 | 43.65 ± 10 |
Age at follow-up MRI (years) | 44 ± 12.8 | 47.8 ± 7.4 |
Disease duration at first MRI (years) | 14 ± 13 | |
Disease duration at follow up MRI (years) | 18 ± 13 | |
SPastic Gate gene | ||
SPG4 | 40% (12) | |
SPG5 | 13% (4) | |
SPG30 | 10% (3) | |
SPG3 | 10% (3) | |
SPG8 | 6% (2) | |
SPG11 | 6% (2) | |
SPG7 | 3% (1) | |
SPG72 | 3% (1) | |
SPG10 | 3% (1) | |
SPG31 | 3% (1) | |
SPG not defined | 3% (1) |